Financhill
Back

Halozyme Therapeutics, Inc. Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing slight selling pressure.

Halozyme Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 69.14 Sell
20-day SMA: 69.5 Sell
50-day SMA: 68.41 Sell
200-day SMA: 63.1 Sell
8-day EMA: 67.4 Sell
20-day EMA: 68.61 Sell
50-day EMA: 68.65 Sell
200-day EMA: 63.67 Sell

Halozyme Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.54 Sell
Relative Strength Index (14 RSI): 32.23 Sell
Chaikin Money Flow: -1763792 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.19 - 71.59) Sell
Bollinger Bands (100): (62.48 - 73.94) Sell

Halozyme Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Halozyme Therapeutics, Inc. Stock

Is Halozyme Therapeutics, Inc. Stock a Buy?

HALO Technical Analysis vs Fundamental Analysis

Buy
63
Halozyme Therapeutics, Inc. (HALO) is a Buy

Is Halozyme Therapeutics, Inc. a Buy or a Sell?

Halozyme Therapeutics, Inc. Stock Info

Market Cap:
7.4B
Price in USD:
62.95
Share Volume:
4.2M

Halozyme Therapeutics, Inc. 52-Week Range

52-Week High:
79.50
52-Week Low:
46.26
Buy
63
Halozyme Therapeutics, Inc. (HALO) is a Buy

Halozyme Therapeutics, Inc. Share Price Forecast

Is Halozyme Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Halozyme Therapeutics, Inc.

Is Halozyme Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.01 per share, and an increase next year of $1.83 per share.

Technical Analysis of Halozyme Therapeutics, Inc.

Should I short Halozyme Therapeutics, Inc. stock?

* Halozyme Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.